In addition to the important role of these metalloproteinases, prostate cancer invasion is also highly dependent upon the activity of the urokinase proteinase system consisting of the serine protease urokinase, its cell surface receptor uPAR and inhibitors such as plasminogen activator inhibitors [5-8]. The gene discussed is CD177; the disease is prostate carcinoma.